Plus Three dives deep into the world of drugs, from local decriminalization and emerging psychedelic corporations to leftist politics and mass incarceration. Each week the team and guests attempt to make sense of the complex connections between drugs, science, capitalism, policy, and culture.

Plus Three dives deep into the world of drugs, from local decriminalization and emerging psychedelic corporations to leftist politics and mass incarceration. Each week the team and guests attempt to make sense of the complex connections between drugs, science, capitalism, policy, and culture.

Plus Three dives deep into the world of drugs, from local decriminalization and emerging psychedelic corporations to leftist politics and mass incarceration. Each week the team and guests attempt to make sense of the complex connections between drugs, science, capitalism, policy, and culture.


Newest Episode

#28 – Qoup At The Qapitol: Q’mon Man

January 13 2021
In this episode, we discuss a prominent participant in the bumbling coup attempt of January 6: "QAnon Shaman" Jake Angeli. Along with a coalition of Donald Trump supporters and assorted right wing ideologues, Angeli stormed the Capitol following a speech by Trump. Featuring a dissection of an "Ascension Masterclass" that was hosted on Angeli's now-deleted Star Seed Academy Facebook page, we (once again) wade into the disturbing world of psychedelic authoritarianism.

Previous

#27 – The Thought Leader and the Critic

December 23 2020
This episode explores the rise of self-styled “thought leaders” within the psychedelic community, using Anand Giridharadas’ book “Winners Take All” as a jumping off point. Although people have been on the conference circuit for years, the recent explosion of capital investments means that there’s an unprecedented potential for money, celebrity, and status in the space.

#26 – Livestream: The Gang Goes Non-Profit

December 3 2020
We kicked off the start of our ongoing livestreams with the announcement of Psymposia's 501(c)(3) non-profit status, discussions of corporadelic dynamics, fond memories of helping people learn how to extract psychedelic drugs during an Ivy League University's psychedelic conference, and a whole bunch of back and forth with the audience about the current state (and future) of psychedelia.

#25 – Press Release: Plus Three found to have neuroprotective effects against corporadelic BS

November 19 2020
In this episode we explore the myriad of problems that result from media outlets treating corporate press releases as though they're legitimate news sources, rather than advertisements. We examine "science by press release" cases ranging from psychedelic pharmaceutical firms who claim their barely-studied compounds are superior to (and safer than) psilocybin (one of the safest psychoactive compounds in the human pharmacopoeia), to students who claimed Oreos were as addictive as cocaine, to pineal DMT, cold fusion, and more.

#24 – From Mining to Mushrooms

November 11 2020
Recorded live at the Capital Psychedelic Summit, hosted virtually in Washington D.C., Russell Hausfeld joins Brian Normand and David Nickles to discuss the infiltration of the psychedelic pharmaceutical industry by companies, investors, and executives from extractive industry. This episode explores the destructive nature of extractive industry and the effects of introducing those dynamics into psychedelia. If the same people destroying Indigenous lands told you they believed in "sacred reciprocity," would you believe them?

#23 – “Grow, Gather, Give” Is an Anti-Capitalist Approach (and That’s a Good Thing)

October 29 2020
Recorded live (online) at the Capital Psychedelic Summit in Washington D.C., the Plus Three crew picks up the threads of a recent panel discussion about the effects of corporations and capitalism on the emerging psychedelic landscape. Examining the logic of capitalism, the realities of medicalization, and the need for radical social transformations, we explore philosophies underlying the "Grow, Gather, Give" model, which the Capital Psychedelic Summit organizers explicitly centered for this event.

#22 – Coronavirus Conspiracy Theories in Psychedelia

October 5 2020
Terence McKenna once mused, “Conspiracy theory is a kind of epistemological cartoon about reality.” Looking around at the world, things appear awfully cartoonish at the moment. We're joined by Psymposia Senior Writer, Russell Hausfeld, to discuss the propagation of coronavirus conspiracies, recent revelations about QAnon, and the likelihood that some "conspiracy" claims are simply warped articulations of systemic critique. 5G won't give you COVID-19, but it sure will help you download this episode faster.

#21 – American Trip: Ido Hartogsohn

September 9 2020
Dr. Ido Hartoghson joins the show to talk about the ideas in his new book, American Trip: Set, Setting, and the Psychedelic Experience in the Twentieth Century  Acknowledging psychedelics as non-specific amplifiers of consciousness, we discuss different historical (and present) paradigms of use in order to interrogate the role of psychedelics within our culture. As we find ourselves staring down a number of existential questions, we must ask ourselves, "What do we hope to achieve through our personal and cultural exposure to psychedelics?”

#20 – The LSD Silo Bust (Everything You Wanted to Know and a Few Things You Didn’t)

August 27 2020
In response to the unexpected early release of William Leonard Pickard from prison, we discuss some of the characters and stories surrounding the case. Having served twenty years of a double life sentence for conspiracy to manufacture, distribute, and dispense LSD— charges which he disputes— Pickard has never spoken publicly about the specifics of his case, and some of the drug-media coverage of this story has evidenced glaring omissions. Using court documents, lesser-known first-person accounts, and excerpts from Pickard's book, The Rose of Paracelsus: On Secrets & Sacraments, we call attention to some of the murkier aspects of this story in an attempt to paint a fuller picture of what is, perhaps, the most notorious psychedelic story of the 21st century.

#19 – MDMA, PTSD, ACAB

August 14 2020
In this episode, we explore the implications of MAPS’ main political strategy: demonstrating affinity for and utility to the police, the military, the far right, and individuals who have repeatedly upheld violent white supremacism. Unpacking a recent article by David Nickles, we examine the “ends justifies the means” logic that has become pervasive in psychedelic research.

#18 – Seizing the Doors of Perception

August 5 2020
In this episode, we unpack some of the characters and dynamics of the psychedelic “arm” of the Intellectual Dark Web. We use Neşe Devenot’s recently released video on Jamie Wheal, Lucian Tarnowski, and other affiliates of the Rebel Wisdom media platform to explore questions of power, class, and ahistorical theories of social change. Just how much sense do these self-labelled "sensemakers" make?

#17 – Psychedelic Capitalists Part 2: Pandemic Profiteers and Non-Cooperative Actors

July 8 2020
Brian, Dave, and Russell continue their conversation about neoliberals in psychedelia, including companies using the coronavirus pandemic to promote psychedelics for mental health. They also deconstruct non-profit vs. for-profit rhetoric and propose more pragmatic frameworks for examining the implications (and material realities) of psychedelic corporations and their operating structures, such as cooperative vs. non-cooperative.

#15 – Psychedelics, Sex, Power, Silence

May 18 2020
In this episode, Lily Kay Ross joins us to discuss Olivia Goldhill’s story, “Psychedelic therapy has a sexual abuse problem.” Ross recently completed her doctorate studying social responses to sexual violence. She brings both her personal experience with sexual violence and poor community responses in psychedelic spaces and her academic insights to bear on the myriad of questions highlighted by Goldhill’s reporting.

#14 – Douglas Rushkoff on the Parallels Between Psychedelic and Digital Mainstreaming

May 1 2020
Plus Three is joined by author and host of the Team Human podcast, Douglas Rushkoff, to discuss some of the parallel trajectories between psychedelic and digital mainstreaming. Will COVID-19 be to psychedelics as 9/11 was to surveillance capitalism? September 11th became the excuse to implement a surveillance state and surrender digital technologies to corporations. Will we see psychedelic medicines become the go-to recovery option for COVID-related mental health fallout? We also explore what a true psychedelic renaissance might look like.

#13 – Dear Psychedelic Researchers

April 14 2020
On the one hand, psychedelics hold promise for personal healing and transformative individual change, and when psychedelics are eventually accepted by mainstream medicine, they will likely impact mental health outcomes for the better. But the broken systems highlighted by the coronavirus pandemic offer insight into why mental health has reached epidemic proportions in the first place.

#12 – Capitalism can’t save us from coronavirus. Neither can psychedelics.

March 26 2020
In the midst of increasing global engagement with the fallout of the novel coronavirus, we examine some responses to the pandemic within the "psychedelic community.” Recognizing that the US has a longstanding history of privatizing profits while socializing costs, we also discuss the normalization of a "capitalist animism"—treating social phenomena like markets or financial capital as living entities—that fixates on "economic health" at the expense of public health. As this unprecedented situation continues to unfold, we explore some considerations for this sudden period of social isolation within a broader culture of social alienation.

#11 + Alan Piper: Strange Nazis

March 11 2020
Alan Piper is a maverick historian of ideas with a penchant for unique, deep dives into rich veins of psychedelia. Piper’s 2015 monograph, Strange Drugs Make for Bedfellows: Ernst Jünger, Albert Hofmann, and the Politics of Psychedelics was foundational for the critique explored in Brian Pace’s controversial Lucy in the Sky with Nazis: Psychedelics and the Right Wing. In this interview, Pace interviews Piper about Hofmann tripping buddy and Wehrmacht Captain Jünger, LSD and ideology— clarifying concepts and dispelling myths.

#9 – Lucy In the Sky with Nazis

February 14 2020
We discuss our recent article, Lucy in the Sky with Nazis: Psychedelics and the Right Wing, which stirred up quite a bit of controversy. So to stir things up a little more, we’ve unpacked some of our perspectives while exploring questions of psychedelics as non-specific amplifiers of consciousness, the far right, the so-called “Intellectual Dark Web,” white supremacy, and psychedelics and social change.

#8 – Manufacturing Authority

February 6 2020
Well, it’s official, psychedelics have entered the corporate-wellness mainstream. If you have any doubts, check out Gwyneth Paltrow’s new Netflix series, The Goop Lab. Or maybe don’t.

#7 – Why We Do What We Do

December 31 2019
The team shares their personal stories and talk about how and why they became involved in psychedelic advocacy and drug policy reform. Happy New Year y’alls.

#5 – Psychedelics X Climate Crisis

December 11 2019
The team explores the Psychedelic/Climate-Change connection, and tools for addressing existential crisis. Climate change is the challenge of our era, but the media still distracts us with comparatively trivial matters.

#4 – Psilocybin Incorporated

October 19 2019
The crew recaps the Economic Models for the Expansion of Psychedelics panel at the Horizons Perspectives on Psychedelics conference in New York. They also discuss the corrosive effects that Compass Pathways, a for-profit psilocybin startup has had in psychedelic science and research.

#2 – Decriminalization Now!

October 1 2019
The historical record is clear - drug prohibition is directly connected to the prosecution of minorities: ethnic or political. Not only do we see a complete lack of scientific or evidentiary basis for prohibition and criminalization, we can see it has been a product of white supremacy, xenophobia, misogyny, and imperialism. 

#1 – We Hope Michael Pollan Changes His Mind

May 19 2019
Michael Pollan thinks we’re not ready to decriminalize psilocybin, despite his media tour where he capitalized on the rising wave of psychedelic normalization. The team critically examines his New York Times op-ed where he urges caution, and why we think he's wrong.

Plus Three goes deep into the world of drugs, from local decriminalization and emerging psychedelic corporations to leftist politics and mass incarceration. Each week the team and guests attempt to make sense of the complex connections between drugs, science, capitalism, policy, and culture.


Newest Episode

#28 – Qoup At The Qapitol: Q’mon Man

January 13 2021
In this episode, we discuss a prominent participant in the bumbling coup attempt of January 6: "QAnon Shaman" Jake Angeli. Along with a coalition of Donald Trump supporters and assorted right wing ideologues, Angeli stormed the Capitol following a speech by Trump. Featuring a dissection of an "Ascension Masterclass" that was hosted on Angeli's now-deleted Star Seed Academy Facebook page, we (once again) wade into the disturbing world of psychedelic authoritarianism.

Previous

#27 – The Thought Leader and the Critic

December 23 2020
This episode explores the rise of self-styled “thought leaders” within the psychedelic community, using Anand Giridharadas’ book “Winners Take All” as a jumping off point. Although people have been on the conference circuit for years, the recent explosion of capital investments means that there’s an unprecedented potential for money, celebrity, and status in the space.

#26 – Livestream: The Gang Goes Non-Profit

December 3 2020
We kicked off the start of our ongoing livestreams with the announcement of Psymposia's 501(c)(3) non-profit status, discussions of corporadelic dynamics, fond memories of helping people learn how to extract psychedelic drugs during an Ivy League University's psychedelic conference, and a whole bunch of back and forth with the audience about the current state (and future) of psychedelia.

#25 – Press Release: Plus Three found to have neuroprotective effects against corporadelic BS

November 19 2020
In this episode we explore the myriad of problems that result from media outlets treating corporate press releases as though they're legitimate news sources, rather than advertisements. We examine "science by press release" cases ranging from psychedelic pharmaceutical firms who claim their barely-studied compounds are superior to (and safer than) psilocybin (one of the safest psychoactive compounds in the human pharmacopoeia), to students who claimed Oreos were as addictive as cocaine, to pineal DMT, cold fusion, and more.

#24 – From Mining to Mushrooms

November 11 2020
Recorded live at the Capital Psychedelic Summit, hosted virtually in Washington D.C., Russell Hausfeld joins Brian Normand and David Nickles to discuss the infiltration of the psychedelic pharmaceutical industry by companies, investors, and executives from extractive industry. This episode explores the destructive nature of extractive industry and the effects of introducing those dynamics into psychedelia. If the same people destroying Indigenous lands told you they believed in "sacred reciprocity," would you believe them?

#23 – “Grow, Gather, Give” Is an Anti-Capitalist Approach (and That’s a Good Thing)

October 29 2020
Recorded live (online) at the Capital Psychedelic Summit in Washington D.C., the Plus Three crew picks up the threads of a recent panel discussion about the effects of corporations and capitalism on the emerging psychedelic landscape. Examining the logic of capitalism, the realities of medicalization, and the need for radical social transformations, we explore philosophies underlying the "Grow, Gather, Give" model, which the Capital Psychedelic Summit organizers explicitly centered for this event.

#22 – Coronavirus Conspiracy Theories in Psychedelia

October 5 2020
Terence McKenna once mused, “Conspiracy theory is a kind of epistemological cartoon about reality.” Looking around at the world, things appear awfully cartoonish at the moment. We're joined by Psymposia Senior Writer, Russell Hausfeld, to discuss the propagation of coronavirus conspiracies, recent revelations about QAnon, and the likelihood that some "conspiracy" claims are simply warped articulations of systemic critique. 5G won't give you COVID-19, but it sure will help you download this episode faster.

#21 – American Trip: Ido Hartogsohn

September 9 2020
Dr. Ido Hartoghson joins the show to talk about the ideas in his new book, American Trip: Set, Setting, and the Psychedelic Experience in the Twentieth Century  Acknowledging psychedelics as non-specific amplifiers of consciousness, we discuss different historical (and present) paradigms of use in order to interrogate the role of psychedelics within our culture. As we find ourselves staring down a number of existential questions, we must ask ourselves, "What do we hope to achieve through our personal and cultural exposure to psychedelics?”

#20 – The LSD Silo Bust (Everything You Wanted to Know and a Few Things You Didn’t)

August 27 2020
In response to the unexpected early release of William Leonard Pickard from prison, we discuss some of the characters and stories surrounding the case. Having served twenty years of a double life sentence for conspiracy to manufacture, distribute, and dispense LSD— charges which he disputes— Pickard has never spoken publicly about the specifics of his case, and some of the drug-media coverage of this story has evidenced glaring omissions. Using court documents, lesser-known first-person accounts, and excerpts from Pickard's book, The Rose of Paracelsus: On Secrets & Sacraments, we call attention to some of the murkier aspects of this story in an attempt to paint a fuller picture of what is, perhaps, the most notorious psychedelic story of the 21st century.

#19 – MDMA, PTSD, ACAB

August 14 2020
In this episode, we explore the implications of MAPS’ main political strategy: demonstrating affinity for and utility to the police, the military, the far right, and individuals who have repeatedly upheld violent white supremacism. Unpacking a recent article by David Nickles, we examine the “ends justifies the means” logic that has become pervasive in psychedelic research.

#18 – Seizing the Doors of Perception

August 5 2020
In this episode, we unpack some of the characters and dynamics of the psychedelic “arm” of the Intellectual Dark Web. We use Neşe Devenot’s recently released video on Jamie Wheal, Lucian Tarnowski, and other affiliates of the Rebel Wisdom media platform to explore questions of power, class, and ahistorical theories of social change. Just how much sense do these self-labelled "sensemakers" make?

#17 – Psychedelic Capitalists Part 2: Pandemic Profiteers and Non-Cooperative Actors

July 8 2020
Brian, Dave, and Russell continue their conversation about neoliberals in psychedelia, including companies using the coronavirus pandemic to promote psychedelics for mental health. They also deconstruct non-profit vs. for-profit rhetoric and propose more pragmatic frameworks for examining the implications (and material realities) of psychedelic corporations and their operating structures, such as cooperative vs. non-cooperative.

#15 – Psychedelics, Sex, Power, Silence

May 18 2020
In this episode, Lily Kay Ross joins us to discuss Olivia Goldhill’s story, “Psychedelic therapy has a sexual abuse problem.” Ross recently completed her doctorate studying social responses to sexual violence. She brings both her personal experience with sexual violence and poor community responses in psychedelic spaces and her academic insights to bear on the myriad of questions highlighted by Goldhill’s reporting.

#14 – Douglas Rushkoff on the Parallels Between Psychedelic and Digital Mainstreaming

May 1 2020
Plus Three is joined by author and host of the Team Human podcast, Douglas Rushkoff, to discuss some of the parallel trajectories between psychedelic and digital mainstreaming. Will COVID-19 be to psychedelics as 9/11 was to surveillance capitalism? September 11th became the excuse to implement a surveillance state and surrender digital technologies to corporations. Will we see psychedelic medicines become the go-to recovery option for COVID-related mental health fallout? We also explore what a true psychedelic renaissance might look like.

#13 – Dear Psychedelic Researchers

April 14 2020
On the one hand, psychedelics hold promise for personal healing and transformative individual change, and when psychedelics are eventually accepted by mainstream medicine, they will likely impact mental health outcomes for the better. But the broken systems highlighted by the coronavirus pandemic offer insight into why mental health has reached epidemic proportions in the first place.

#12 – Capitalism can’t save us from coronavirus. Neither can psychedelics.

March 26 2020
In the midst of increasing global engagement with the fallout of the novel coronavirus, we examine some responses to the pandemic within the "psychedelic community.” Recognizing that the US has a longstanding history of privatizing profits while socializing costs, we also discuss the normalization of a "capitalist animism"—treating social phenomena like markets or financial capital as living entities—that fixates on "economic health" at the expense of public health. As this unprecedented situation continues to unfold, we explore some considerations for this sudden period of social isolation within a broader culture of social alienation.

#11 + Alan Piper: Strange Nazis

March 11 2020
Alan Piper is a maverick historian of ideas with a penchant for unique, deep dives into rich veins of psychedelia. Piper’s 2015 monograph, Strange Drugs Make for Bedfellows: Ernst Jünger, Albert Hofmann, and the Politics of Psychedelics was foundational for the critique explored in Brian Pace’s controversial Lucy in the Sky with Nazis: Psychedelics and the Right Wing. In this interview, Pace interviews Piper about Hofmann tripping buddy and Wehrmacht Captain Jünger, LSD and ideology— clarifying concepts and dispelling myths.

#9 – Lucy In the Sky with Nazis

February 14 2020
We discuss our recent article, Lucy in the Sky with Nazis: Psychedelics and the Right Wing, which stirred up quite a bit of controversy. So to stir things up a little more, we’ve unpacked some of our perspectives while exploring questions of psychedelics as non-specific amplifiers of consciousness, the far right, the so-called “Intellectual Dark Web,” white supremacy, and psychedelics and social change.

#8 – Manufacturing Authority

February 6 2020
Well, it’s official, psychedelics have entered the corporate-wellness mainstream. If you have any doubts, check out Gwyneth Paltrow’s new Netflix series, The Goop Lab. Or maybe don’t.

#7 – Why We Do What We Do

December 31 2019
The team shares their personal stories and talk about how and why they became involved in psychedelic advocacy and drug policy reform. Happy New Year y’alls.

#5 – Psychedelics X Climate Crisis

December 11 2019
The team explores the Psychedelic/Climate-Change connection, and tools for addressing existential crisis. Climate change is the challenge of our era, but the media still distracts us with comparatively trivial matters.

#4 – Psilocybin Incorporated

October 19 2019
The crew recaps the Economic Models for the Expansion of Psychedelics panel at the Horizons Perspectives on Psychedelics conference in New York. They also discuss the corrosive effects that Compass Pathways, a for-profit psilocybin startup has had in psychedelic science and research.

#2 – Decriminalization Now!

October 1 2019
The historical record is clear - drug prohibition is directly connected to the prosecution of minorities: ethnic or political. Not only do we see a complete lack of scientific or evidentiary basis for prohibition and criminalization, we can see it has been a product of white supremacy, xenophobia, misogyny, and imperialism. 

#1 – We Hope Michael Pollan Changes His Mind

May 19 2019
Michael Pollan thinks we’re not ready to decriminalize psilocybin, despite his media tour where he capitalized on the rising wave of psychedelic normalization. The team critically examines his New York Times op-ed where he urges caution, and why we think he's wrong.